Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, Next
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2023-02-14
4:19 pm
Purchase		13GProthena Corporation plc
PRTA		Avidity Partners Management LP2,953,000
5.7%		2,953,000increase
(New Position)		View
2023-02-14
4:07 pm
Purchase		13GSyros Pharmaceuticals, Inc.
SYRS		Avidity Partners Management LP2,189,719
9.9%		69,719increase
(+3.29%)		View
2023-02-14
3:59 pm
Purchase		13GSCYNEXIS, Inc.
SCYX		Avidity Partners Management LP3,624,523
9.9%		1,385,245increase
(+61.86%)		View
2023-02-14
3:52 pm
Sale		13GESSA Pharma Inc.
EPIX		Avidity Partners Management LP1,855,400
4.2%		-1,894,600decrease
(-50.52%)		View
2023-02-14
3:49 pm
Purchase		13GAltimmune, Inc.
ALT		Avidity Partners Management LP3,990,000
8.1%		1,225,000increase
(+44.30%)		View
2023-02-14
3:47 pm
Purchase		13GSyndax Pharmaceuticals, Inc.
SNDX		Avidity Partners Management LP6,718,142
9.7%		1,474,123increase
(+28.11%)		View
2023-02-14
3:44 pm
Purchase		13GKezar Life Sciences, Inc.
KZR		Avidity Partners Management LP6,782,400
9.9%		3,554,200increase
(+110.10%)		View
2023-02-14
3:39 pm
Purchase		13GIDEAYA Biosciences, Inc.
IDYA		Avidity Partners Management LP3,824,800
7.9%		1,271,800increase
(+49.82%)		View
2023-02-14
3:38 pm
Sale		13GAlpine Immune Sciences, Inc.
ALPN		Avidity Partners Management LP1,888,887
4%		-316,800decrease
(-14.36%)		View
2023-02-14
3:31 pm
Purchase		13GKaryopharm Therapeutics Inc.
KPTI		Avidity Partners Management LP11,381,073
9.9%		29,254increase
(+0.26%)		View
2023-02-14
3:23 pm
Sale		13GGritstone bio, Inc.
GRTS		Avidity Partners Management LP2,859,971
3.3%		-4,130,223decrease
(-59.09%)		View
2023-02-14
2:58 pm
Purchase		13GAkero Therapeutics, Inc.
AKRO		Avidity Partners Management LP3,825,000
8.2%		720,000increase
(+23.19%)		View
2023-02-14
2:42 pm
Sale		13GCyteir Therapeutics, Inc.
CYT		Avidity Partners Management LP1,795,800
5.1%		-53,738decrease
(-2.91%)		View
2023-02-14
2:26 pm
Sale		13GPhaseBio Pharmaceuticals Inc
PHAS		Avidity Partners Management LP2,040,000
4.1%		-2,365,000decrease
(-53.69%)		View
2023-02-14
1:58 pm
Purchase		13GPhathom Pharmaceuticals, Inc.
PHAT		Avidity Partners Management LP1,900,000
4.6%		4,000increase
(+0.21%)		View
2023-02-14
1:38 pm
Purchase		13GArvinas, Inc.
ARVN		Avidity Partners Management LP4,950,000
9.3%		1,710,162increase
(+52.79%)		View
2023-02-14
1:10 pm
Sale		13GIVERIC bio, Inc.
ISEE		Avidity Partners Management LP838,407
0.6%		-6,116,593decrease
(-87.95%)		View
2023-02-14
12:50 pm
Sale		13GOncoSec Medical Incorporated
ONCS		Avidity Partners Management LP0
0%		-2,945,000decrease
(Position Closed)		View
2023-02-14
12:41 pm
Sale		13GAdicet Bio, Inc.
ACET		Avidity Partners Management LP0
0%		-3,034,004decrease
(Position Closed)		View
2023-02-14
12:19 pm
Sale		13GViridian Therapeutics, Inc.
VRDN		Avidity Partners Management LP0
0%		-1,278,261decrease
(Position Closed)		View
Goto 0, 1, 2, 3, Next